Megha Katti

Enthusiast
DISC Type : i

Head of Business Intelligence and Analytics, Rare Portfolio at Apellis Pharmaceuticals

Boston, Massachusetts, United States

Overview

Megha Katti heads Business Intelligence and Analytics for the Rare Portfolio at Apellis Pharmaceuticals. An MBA from Harvard Business School, she specializes in commercial insights and strategic forecasting for rare diseases, with prior leadership roles at Sarepta Therapeutics and Alnylam Pharmaceuticals.

She has deep experience leading commercial opportunity assessments and developing revenue forecasts for multiple pipeline products to guide company investment decisions.

Personality Overview

Amiable & Agreeable

Consensus Focused

Non-Confrontational

They are more about building relationships than just cutting deals.  Unlike D or C types, they are convinced more by stories and testimonials. They are generally friendly, so be careful when relying on their word.

Topics They Care About

Rare Disease Strategy
Her current role at Apellis is focused on their "Rare Portfolio, " and her prior experience includes commercializing products for rare diseases.
Commercial Analytics
Her career has centered on leading commercial insights and analytics teams at multiple pharmaceutical companies to drive strategy.
Strategic Forecasting
She has led the development of probabilistic revenue forecasts for pipeline products to inform long-range planning and investment decisions.

Media Appearances

Megha has no verified media appearances

Work History

9-2025
Head of Business Intelligence and Analytics, Rare Portfolio at Apellis Pharmaceuticals
3-2025 - 9-2025
Senior Director, Commercial Insights & Analytics at Sarepta Therapeutics
9-2022 - 3-2025
Director, Commercial Insights & Analytics at Sarepta Therapeutics
3-2022 - 8-2022
Associate Director, New Product Commercialization Insights Lead at Alnylam Pharmaceuticals
9-2019 - 3-2022
Associate Director, Market Insights: TTR Forecasting and Performance Lead at Alnylam Pharmaceuticals

Education

Master of Business Administration (MBA) from Harvard Business School
2004 - 2008
ScB from Brown University

More Information

Social Presence :

Prographics :

Exp : 9 Location : Boston, Massachusetts, United States Job Level : Mid-senior Designation : Head of Business Intelligence and Analytics, Rare Portfolio at Apellis Pharmaceuticals
URL has been copied!

Insights For Selling To Megha

During A Call Or A Meeting

DO's

  • Ask them how their day is going or exchange some other pleasantries
  • Give them the opportunity to lead the conversation where possible
  • Invite them for a lunch or a drink/coffee

DONT's

  • Don’t push them for a direct ‘no’, take lack of ‘yes’ as ‘no’ after some time
  • Don’t be excessively objective, be like a storyteller with them
  • Avoid overloading them with too much information

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Megha is

  • Relationships and rapport matter to them, but so does the value of the product.
  • Will you ever get a clear answer from Megha

  • They will hardly ever say a direct no.

Insights For Deal Planning

    How fast (or slow) will Megha move?

  • Even when they are constantly engaged, they do not reach decisions quickly.
  • Can Megha take some risk or not?

  • If it seems really necessary, they can take small risks.

You And Megha

Personality Compatibility


Other Apellis Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.